-
Subject Areas on Research
-
111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.
-
18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL.
-
A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men.
-
A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix: A Distinct Subset of Low-Grade Squamous Intraepithelial Lesion, Proposing a Possible Cell of Origin.
-
A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer.
-
A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES).
-
A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.
-
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.
-
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
-
A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma.
-
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.
-
A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma.
-
A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease.
-
A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate.
-
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.
-
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
-
ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.
-
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer.
-
ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
-
ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma.
-
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
-
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.
-
Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?
-
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.
-
Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
-
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
-
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
-
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
-
African American Men With Low-Risk Prostate Cancer Are Candidates for Active Surveillance: The Will-Rogers Effect?
-
African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center.
-
African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
-
Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.
-
Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial.
-
Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset.
-
An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer.
-
An update on noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
-
Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma.
-
Anatomic tumor location influences the success of contemporary limb-sparing surgery and radiation among adults with soft tissue sarcomas of the extremities.
-
Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.
-
Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
-
Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation.
-
Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.
-
Assessment of intra-observer variability in measurement of high-grade brain tumors.
-
Assessment of multimodality therapy use for extremity sarcoma in the United States.
-
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
-
Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer.
-
Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database.
-
Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.
-
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
-
BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.
-
BCR-NTRK2 fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behavior.
-
Bevacizumab for the treatment of high-grade glioma.
-
Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.
-
Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer.
-
Blood and dietary magnesium levels are not linked with lower prostate cancer risk in black or white men.
-
Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study.
-
Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.
-
Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter?
-
Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate.
-
Cabozantinib in genitourinary malignancies.
-
Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?
-
Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
-
Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy.
-
Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases.
-
Cerebrovascular reactivity mapping in patients with low grade gliomas undergoing presurgical sensorimotor mapping with BOLD fMRI.
-
Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
-
Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database.
-
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
-
Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.
-
Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality (bria).
-
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
-
Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011.
-
Comprehensive Surgical Treatment as the Mainstay of Management in Retroperitoneal Sarcomas: Retrospective Study from Two Non-sarcoma Specialist Centers.
-
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
-
Concordant, non-atypical breast papillomas do not require surgical excision: A 10-year multi-institution study and review of the literature.
-
Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer.
-
Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer.
-
Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer.
-
Counterpoint: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?
-
Cullin-1 and -2 Protein Expression in Colorectal Cancer: Correlation with Clinicopathological Variables.
-
DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial.
-
DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.
-
Defining a textbook surgical outcome for patients undergoing surgical resection of intermediate and high-grade soft tissue sarcomas of the extremities.
-
Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.
-
Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
-
Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS).
-
Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma.
-
Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis.
-
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
-
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.
-
Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy.
-
Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men.
-
Differential expression of immune related genes in high-grade ovarian serous carcinoma.
-
Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
-
Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
-
Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis.
-
Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations.
-
Do all men with pathological Gleason score 8-10 prostate cancer have poor outcomes? Results from the SEARCH database.
-
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
-
Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance?
-
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.
-
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.
-
Early-Life Alcohol Intake and High-Grade Prostate Cancer: Results from an Equal-Access, Racially Diverse Biopsy Cohort.
-
Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
-
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.
-
Efficiency of colorectal cancer care among veterans: analysis of treatment wait times at Veterans Affairs Medical Centers.
-
Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort.
-
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.
-
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
-
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
-
Evidence of a genetic link between endometriosis and ovarian cancer.
-
Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.
-
Evolving management of low grade glioma: No consensus amongst treating clinicians.
-
Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma.
-
Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer.
-
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
-
Factors influencing Oncotype DX use in the management of early breast cancer: a single centre experience.
-
Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
-
Familial gliomas: cases in two pairs of brothers.
-
Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
-
Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
-
First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database.
-
First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.
-
Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
-
Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.
-
Frequency of "incidental" serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study.
-
Frequency of breast cancer subtypes among African American women in the AMBER consortium.
-
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.
-
GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".
-
Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
-
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.
-
Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.
-
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
-
Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
-
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.
-
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
-
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
-
Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case-control study.
-
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
-
HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
-
High-fructose corn syrup enhances intestinal tumor growth in mice.
-
High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis.
-
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.
-
Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.
-
Histotype classification of ovarian carcinoma: A comparison of approaches.
-
Hormone naïve prostate cancer: predicting and maximizing response intervals.
-
Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.
-
Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.
-
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
-
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.
-
Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.
-
Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers.
-
Improved grading of IDH-mutated astrocytic gliomas.
-
Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas.
-
In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
-
In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer.
-
Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells.
-
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.
-
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.
-
Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution.
-
Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.
-
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival.
-
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
-
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
-
Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia.
-
Is Body Mass Index the Best Adiposity Measure for Prostate Cancer Risk? Results From a Veterans Affairs Biopsy Cohort.
-
Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?
-
Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium.
-
LGR5 in Barrett's Esophagus and its Utility in Predicting Patients at Increased Risk of Advanced Neoplasia.
-
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
-
Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46.
-
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
-
Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.
-
Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml.
-
Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
-
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02).
-
Low-risk and very-low-risk prostate cancer: is there a role for focal therapy in the era of active surveillance? Yes, the two approaches complement each other.
-
MRI/TRUS fusion vs. systematic biopsy: intra-patient comparison of diagnostic accuracy for prostate cancer using PI-RADS v2.
-
MYC/BCL2 double-hit high-grade B-cell lymphoma.
-
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
-
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.
-
Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.
-
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.
-
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
-
Metformin use and risk of prostate cancer: results from the REDUCE study.
-
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers.
-
Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.
-
Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.
-
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.
-
Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.
-
Most Gleason 8 Biopsies are Downgraded at Prostatectomy-Does 4 + 4 = 7?
-
Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.
-
Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer.
-
Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma.
-
Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
-
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas.
-
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.
-
Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals.
-
New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?
-
Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond.
-
Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
-
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.
-
Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
-
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
-
Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer.
-
Obesity, weight gain, and ovarian cancer risk in African American women.
-
Oncological and Functional Outcomes of Patients Undergoing Individualized Partial Gland Cryoablation of the Prostate: A Single-Institution Experience.
-
Open surgical partial nephrectomy for upper tract urothelial carcinoma.
-
Open versus laparoscopic portal lymphadenectomy in gallbladder cancer: is there a difference in lymph node yield?
-
Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.
-
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.
-
Over half of contemporary clinical Gleason 8 on prostate biopsy are downgraded at radical prostatectomy.
-
Pancreatic Neuroendocrine Tumors.
-
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
-
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.
-
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease.
-
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
-
Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort.
-
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
-
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor.
-
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.
-
Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium.
-
Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen.
-
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.
-
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
-
Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
-
Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?
-
Positive surgical margins in radical prostatectomy patients do not predict long-term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort.
-
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.
-
Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies.
-
Predicting biopsy-proven prostate cancer recurrence following cryosurgery.
-
Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database.
-
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer.
-
Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.
-
Predictors of Rectourethral Fistula Formation After Primary Whole-Gland Cryoablation for Prostate Cancer: Results from the Cryo On-Line Database Registry.
-
Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
-
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomy.
-
Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.
-
Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
-
Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance.
-
Preoperative predictors of pathologic stage T2a in low-risk prostate cancer: implications for focal therapy.
-
Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.
-
Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis.
-
Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry.
-
Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.
-
Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma.
-
Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models.
-
Prognostic marker analysis in pediatric intracranial ependymomas.
-
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma.
-
Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy.
-
Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis.
-
Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
-
Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
-
Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
-
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
-
RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques.
-
Race-associated biological differences among Luminal A breast tumors.
-
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.
-
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
-
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
-
Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance).
-
Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.
-
Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients.
-
Re: Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9-10 Prostate Cancer.
-
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
-
Rising PSA Level in an Anxious Postprostatectomy Patient.
-
Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?
-
Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity.
-
Role of 18 F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma.
-
Role of Increased n-acetylaspartate Levels in Cancer.
-
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.
-
Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
-
Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
-
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?
-
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
-
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
-
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.
-
Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.
-
Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?
-
Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
-
Simpson Grade I-III Resection of Spinal Atypical (World Health Organization Grade II) Meningiomas is Associated With Symptom Resolution and Low Recurrence.
-
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
-
Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial.
-
Smoking and risk of low- and high-grade prostate cancer: results from the REDUCE study.
-
Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
-
Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer.
-
Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.
-
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
-
Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?
-
Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities.
-
Surveillance after prostate focal therapy.
-
Survival and low-grade glioma: the emergence of genetic information.
-
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
-
Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.
-
Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?
-
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.
-
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
-
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
-
The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.
-
The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role?
-
The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.
-
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
-
The Role of Surgery for Pancreatic Neuroendocrine Tumors.
-
The association between sexual function and prostate cancer risk in US veterans.
-
The effect of the setting of a positive surgical margin in soft tissue sarcoma.
-
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
-
The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
-
The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer.
-
The role of magnetic resonance imaging in delineating clinically significant prostate cancer.
-
The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343.
-
The use of fluorescein sodium in the biopsy and gross-total resection of a tectal plate glioma.
-
The use of radiation therapy in localized high-grade soft tissue sarcoma and potential impact on survival.
-
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer.
-
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
-
Transcript expression in endometrial cancers from Black and White patients.
-
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.
-
Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection.
-
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
-
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
-
Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
-
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.
-
US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy.
-
Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.
-
Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.
-
Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.
-
Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.
-
Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS).
-
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.
-
Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.
-
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.
-
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
-
Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment.
-
[Femur reconstruction using combined autologous fibula transfer and humeral allograft].
-
Keywords of People
-
-
Berchuck, Andrew,
James M. Ingram Distinguished Professor of Gynecologic Oncology,
Obstetrics and Gynecology, Gynecologic Oncology
-
McLendon, Roger Edwin,
Professor of Pathology,
Pathology
-
Moorman, Patricia Gripka,
Professor Emeritus in Family Medicine and Community Health,
Duke Cancer Institute
-
Preminger, Glenn Michael,
James F. Glenn, M.D. Distinguished Professor of Urology,
Surgery, Urology
-
Roy Choudhury, Kingshuk,
Adjunct Associate Professor in the Department of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Sampson, John Howard,
Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine,
Biomedical Engineering
-
Yan, Hai,
Adjunct Professor of Pathology,
Pathology
-
Zafar, Syed Yousuf,
Adjunct Professor in the Department of Medicine,
Duke Science & Society